Why You Should Download This Series:
- Drug Landscape – An in-depth analysis of the gene therapy drug landscape, featuring a detailed review of Pfizer & Spark Therapeutics’ BEQVEZ, the second AAV gene therapy approved for Hemophilia B, and the latest advancements in viral and non-viral delivery systems.
- Trials and Regulatory Announcements – A review of 104 new gene therapy trials initiated in 2024, a promising 24% CAGR in trial activity since 2019, and insights into 7.1% of trials that have seen status changes, including terminations, suspensions, and withdrawals. Stay informed on key regulatory announcements and their impact on the market.
- Emerging Trends and Market Insights – A comprehensive review of major deals from H1 2024 and an overview of the key companies operating in the gene therapy space. Discover the latest emerging trends and how evolving partnerships are influencing innovation and market opportunities.
Why Beacon? Our series is powered by Beacon’s extensive database, offering the ability to filter and analyze over 176 unique delivery systems, 67 editing technologies, and 469 genes/mutations. Gain insights into AAV serotypes, non-viral systems, and more to benchmark your pipeline and drive confident, data-backed investment decisions.
Prepare for the future of gene therapy with the insights and data that matter. Download our H1 2024 Landscape Review Series today.
You May Also Be Interested In...
H1 2024 Immune Tolerance Landscape Review
H1 2024 RNA Landscape Review
H1 2024 Gene Therapy Landscape Review
H1 2024 Cell Therapy Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
